1,305 Shares in UnitedHealth Group Incorporated $UNH Purchased by Alan B Lancz & Associates Inc.

Key Points

• Alan B Lancz & Associates Inc. purchased a new position in UnitedHealth Group, acquiring 1,305 shares valued at approximately $407,000 during the second quarter.
• Despite missing quarterly earnings expectations, UnitedHealth reported a 12.9% revenue increase year-over-year, with quarterly revenue of $111.62 billion.
• Research analysts have responded by raising their price targets for the stock, with KeyCorp setting a new target of $400.00 and Bank of America increasing theirs to $390.00.

Alan B Lancz & Associates Inc. bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 1,305 shares of the healthcare conglomerate's stock, valued at approximately $407,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Sentry Investment Management LLC grew its holdings in UnitedHealth Group by 38.4% in the 2nd quarter. Sentry Investment Management LLC now owns 4,170 shares of the healthcare conglomerate's stock valued at $1,283,000 after buying an additional 1,157 shares in the last quarter. Eos Management L.P. acquired a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $1,511,000. Swan Global Investments LLC increased its position in UnitedHealth Group by 101.9% during the second quarter. Swan Global Investments LLC now owns 1,147 shares of the healthcare conglomerate's stock worth $358,000 after purchasing an additional 579 shares during the last quarter. Cidel Asset Management Inc. boosted its holdings in UnitedHealth Group by 20.7% in the 2nd quarter. Cidel Asset Management Inc. now owns 6,511 shares of the healthcare conglomerate's stock valued at $2,031,000 after purchasing an additional 1,118 shares during the last quarter. Finally, Crux Wealth Advisors increased its holdings in shares of UnitedHealth Group by 10.6% during the 2nd quarter. Crux Wealth Advisors now owns 2,002 shares of the healthcare conglomerate's stock worth $625,000 after buying an additional 192 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 0.0%

Shares of UNH stock opened at $356.53 on Monday. The stock has a market capitalization of $322.90 billion, a P/E ratio of 15.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.47. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a 50 day moving average price of $329.38 and a 200 day moving average price of $342.24.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group's payout ratio is currently 38.30%.

Analysts Set New Price Targets

Several research analysts recently weighed in on UNH shares. KeyCorp increased their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 8th. Truist Financial raised their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research report on Tuesday, September 9th. Bank of America upped their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a "neutral" rating in a research report on Wednesday, October 8th. Weiss Ratings reissued a "sell (d+)" rating on shares of UnitedHealth Group in a research note on Wednesday, October 8th. Finally, Sanford C. Bernstein increased their price objective on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 8th. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $385.13.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.